SPOTLight
The Severn Pleural Outcomes and Therapies: Long-term Insights (SPOTLight) study is a multi-year cohort study, based at Southmead Hospital, looking to improve understanding and diagnostic methods in patients with undiagnosed pleural effusions.
Funded by The Southmead Hospital Charity and Rocket Medical, SPOTLight will investigate:
which biological, radiological, and physiological biomarkers aid in the diagnosis and management of patients with pleural disease, and
how these biomarkers and clinical outcomes relate to patient-reported outcome measures and experiences.
The study aims to recruit at least 100 patients per year, many of whom will also be invited to participate in public involvement activities. It utilises a flexible, adaptive design to ensure a broad range of research questions can be answered and also aims to support the next generation of successful pleural research at Southmead Hospital, by acting as a platform for future collaborations and grants.